
Novel sensitizer of BRAF wild-type melanoma cells to vemurafenib, significantly reducing melanoma клетка viability, with limited toxicity for normal human fibroblasts
Novel sensitizer of BRAF wild-type melanoma cells to vemurafenib, significantly reducing melanoma cell viability, with limited toxicity for normal human fibroblasts
Только для научно-исследовательского применения. Не предназначено для использования у пациентов или в качестве лекарственного средства.